The DOI matches its Crossref record; 51 of the 51 references it cites were found in a registry or an index.
Bacteriocins, Potent Antimicrobial Peptides and the Fight against Multi Drug Resistant Species: Resistance Is Futile?
Open accessAbstract
Despite highly specialized international interventions and policies in place today, the rapid emergence and dissemination of resistant bacterial species continue to occur globally, threatening the longevity of antibiotics in the medical sector. In particular, problematic nosocomial infections caused by multidrug resistant Gram-negative pathogens present as a major burden to both patients and healthcare systems, with annual mortality rates incrementally rising. Bacteriocins, peptidic toxins produced by bacteria, offer promising potential as substitutes or conjugates to current therapeutic compounds. These non-toxic peptides exhibit significant potency against certain bacteria (including multidrug-resistant species), while producer strains remain insusceptible to the bactericidal peptides. The selectivity and safety profile of bacteriocins have been highlighted as superior advantages over traditional antibiotics; however, many aspects regarding their efficacy are still unknown. Although active at low concentrations, bacteriocins typically have low in vivo stability, being susceptible to degradation by proteolytic enzymes. Another major drawback lies in the feasibility of large-scale production, with these key features collectively limiting their current clinical application. Though such limitations require extensive research, the concept of expanding bacteriocins from food preservation to human health opens many fascinating doors, including novel drug delivery systems and anticancer treatment applications.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Jenssen, H., Hamill, P., & Hancock, R. E. W. (2006) · Clinical Microbiology Reviews · doi:10.1128/cmr.00056-05 · Cited by 2,518
Bacteriocins: Developing innate immunity for food
Cotter, P. D., Hill, C., & Ross, R. P. (2005) · Nature Reviews Microbiology · doi:10.1038/nrmicro1273 · Cited by 2,380 · cited 3×
“, mersacidin) of class I bacteriocins act via enzyme inhibition on essential enzymes of the target cell [9], whereas class III bacteriocins have antibacterial activity via the lysis of sensitive cells by catalysing cell‐wall hydrolysis [33].”
BackgroundAntimicrobial Peptides: An Emerging Category of Therapeutic Agents
Mahlapuu, M., Håkansson, J., Ringstad, L., & Björn, C. (2016) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2016.00194 · Cited by 1,927
Studies on anticancer activities of antimicrobial peptides
Hoskin, D. W., & Ramamoorthy, A. (2008) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/j.bbamem.2007.11.008 · Cited by 1,296
Antibacterial activities of bacteriocins: application in foods and pharmaceuticals
Yang, S.-C., Lin, C.-H., Sung, C. T., & Fang, J.-Y. (2014) · Frontiers in Microbiology · doi:10.3389/fmicb.2014.00241 · Cited by 726
Mokoena, M. P. (2017) · Molecules · doi:10.3390/molecules22081255 · Cited by 672
Biomedical applications of nisin
Shin, J. M., Gwak, J. W., Kamarajan, P., Fenno, J. C., Rickard, A. H., & Kapila, Y. L. (2016) · Journal of Applied Microbiology · doi:10.1111/jam.13033 · Cited by 607
Application of bacteriocins and protective cultures in dairy food preservation
Silva, C. C. G., Silva, S. P. M., & Ribeiro, S. C. (2018) · Frontiers in Microbiology · doi:10.3389/fmicb.2018.00594 · Cited by 601
Novel bacteriocins from lactic acid bacteria (LAB): various structures and applications
Perez, R. H., Zendo, T., & Sonomoto, K. (2014) · Microbial Cell Factories · doi:10.1186/1475-2859-13-s1-s3 · Cited by 575
Kumariya, R., Garsa, A. K., Rajput, Y. S., Sood, S. K., Akhtar, N., & Patel, S. (2019) · Microbial Pathogenesis · doi:10.1016/j.micpath.2019.01.002 · Cited by 455
Campylobacteriosis: the role of poultry meat
Skarp, C. P. A., Hänninen, M.-L., & Rautelin, H. I. K. (2016) · Clinical Microbiology and Infection · doi:10.1016/j.cmi.2015.11.019 · Cited by 433
Harkins, C. P., Pichon, B., Doumith, M., Parkhill, J., Westh, H., Tomasz, A., de Lencastre, H., Bentley, S. D., Kearns, A. M., & Holden, M. T. G. (2017) · Genome Biology · doi:10.1186/s13059-017-1252-9 · Cited by 323
Böttger, R., Hoffmann, R., & Knappe, D. (2017) · PLOS ONE · doi:10.1371/journal.pone.0178943 · Cited by 307
Bacteriocins as Potential Anticancer Agents
Kaur, S., & Kaur, S. (2015) · Frontiers in Pharmacology · doi:10.3389/fphar.2015.00272 · Cited by 269
Antibiotics: from prehistory to the present day
Gould, K. (2016) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkv484 · Cited by 268
Bacteriocin-Antimicrobial Synergy: A Medical and Food Perspective
Mathur, H., Field, D., Rea, M. C., Cotter, P. D., Hill, C., & Ross, R. P. (2017) · Frontiers in Microbiology · doi:10.3389/fmicb.2017.01205 · Cited by 233
Bacteriophages as Alternatives to Antibiotics in Clinical Care
Romero-Calle, D., Guimarães Benevides, R., Góes-Neto, A., & Billington, C. (2019) · Antibiotics · doi:10.3390/antibiotics8030138 · Cited by 225
A brief history of antibiotics and select advances in their synthesis
Nicolaou, K. C., & Rigol, S. (2018) · The Journal of Antibiotics · doi:10.1038/ja.2017.62 · Cited by 222
Ribosomally encoded antibacterial proteins and peptides from Pseudomonas
Ghequire, M. G. K., & De Mot, R. (2014) · FEMS Microbiology Reviews · doi:10.1111/1574-6976.12079 · Cited by 214
Fighting biofilms with lantibiotics and other groups of bacteriocins
Mathur, H., Field, D., Rea, M. C., Cotter, P. D., Hill, C., & Ross, R. P. (2018) · npj Biofilms and Microbiomes · doi:10.1038/s41522-018-0053-6 · Cited by 213
Dicks, L. M. T., Dreyer, L., Smith, C., & van Staden, A. D. (2018) · Frontiers in Microbiology · doi:10.3389/fmicb.2018.02297 · Cited by 189
Resistance to bacteriocins produced by Gram-positive bacteria
Bastos, M. D. C. D. F., Coelho, M. L. V., & Santos, O. C. D. S. (2015) · Microbiology · doi:10.1099/mic.0.082289-0 · Cited by 181
Antimicrobial potential of bacteriocins in poultry and swine production
Ben Lagha, A., Haas, B., Gottschalk, M., & Grenier, D. (2017) · Veterinary Research · doi:10.1186/s13567-017-0425-6 · Cited by 174
Microcins in Enterobacteriaceae: Peptide Antimicrobials in the Eco-Active Intestinal Chemosphere
Baquero, F., Lanza, V. F., Baquero, M.-R., del Campo, R., & Bravo-Vázquez, D. A. (2019) · Frontiers in Microbiology · doi:10.3389/fmicb.2019.02261 · Cited by 171
Bacteriocins: Novel Solutions to Age Old Spore-Related Problems?
Egan, K., Field, D., Rea, M. C., Ross, R. P., Hill, C., & Cotter, P. D. (2016) · Frontiers in Microbiology · doi:10.3389/fmicb.2016.00461 · Cited by 170
Mobilization of Microbiota Commensals and Their Bacteriocins for Therapeutics
Hols, P., Ledesma-García, L., Gabant, P., & Mignolet, J. (2019) · Trends in Microbiology · doi:10.1016/j.tim.2019.03.007 · Cited by 168
Preservation of Meat Products with Bacteriocins Produced by Lactic Acid Bacteria Isolated from Meat
da Costa, R. J., Voloski, F. L. S., Mondadori, R. G., Duval, E. H., & Fiorentini, Â. M. (2019) · Journal of Food Quality · doi:10.1155/2019/4726510 · Cited by 165
Structural Insights into Thioether Bond Formation in the Biosynthesis of Sactipeptides
Grove, T. L., Himes, P. M., Hwang, S., Yumerefendi, H., Bonanno, J. B., Kuhlman, B., Almo, S. C., & Bowers, A. A. (2017) · Journal of the American Chemical Society · doi:10.1021/jacs.7b01283 · Cited by 163
Circular Bacteriocins: Biosynthesis and Mode of Action
Gabrielsen, C., Brede, D. A., Nes, I. F., & Diep, D. B. (2014) · Applied and Environmental Microbiology · doi:10.1128/aem.02284-14 · Cited by 160
Hetz, C. A., Bono, M. R., Barros, L. F., & Lagos, R. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.052709699 · Cited by 160
Tong, Z., Zhang, Y., Ling, J., Ma, J., Huang, L., & Zhang, L. (2014) · PLoS ONE · doi:10.1371/journal.pone.0089209 · Cited by 149
Bacteriocins: Perspective for the development of novel anticancer drugs
Baindara, P., Korpole, S., & Grover, V. (2018) · Applied Microbiology and Biotechnology · doi:10.1007/s00253-018-9420-8 · Cited by 139
Anticancer properties of a defensin like class IId bacteriocin Laterosporulin10
Baindara, P., Gautam, A., Raghava, G. P. S., & Korpole, S. (2017) · Scientific Reports · doi:10.1038/srep46541 · Cited by 123
Bacteriocins and Bacteriophages: Therapeutic Weapons for Gastrointestinal Diseases?
Lopetuso, L. R., Giorgio, M. E., Saviano, A., Scaldaferri, F., Gasbarrini, A., & Cammarota, G. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20010183 · Cited by 115
Developing bacteriocins of lactic acid bacteria into next generation biopreservatives
Field, D., Ross, R. P., & Hill, C. (2018) · Current Opinion in Food Science · doi:10.1016/j.cofs.2018.02.004 · Cited by 112
Ongey, E. L., & Neubauer, P. B. (2016) · Microbial Cell Factories · doi:10.1186/s12934-016-0502-y · Cited by 107
Abanoz, H. S., & Kunduhoğlu, B. (2018) · Korean Journal for Food Science of Animal Resources · doi:10.5851/kosfa.2018.e40 · Cited by 105
Field, D., Daly, K., O’Connor, P. M., Cotter, P. D., Hill, C., & Ross, R. P. (2015) · Applied and Environmental Microbiology · doi:10.1128/aem.00070-15 · Cited by 70
The glycocins: in a class of their own
Norris, G. E., & Patchett, M. L. (2016) · Current Opinion in Structural Biology · doi:10.1016/j.sbi.2016.09.003 · Cited by 69
Bacterial Proteinaceous Compounds With Multiple Activities Toward Cancers and Microbial Infection
Rodrigues, G. R., Silveira, G. G. D. O. S., Buccini, D. F., Duque, H. M., Dias, S. C., & Franco, O. L. (2019) · Frontiers in Microbiology · doi:10.3389/fmicb.2019.01690 · Cited by 60
Insights into the Mechanism of Action of the Two-Peptide Lantibiotic Lacticin 3147
Bakhtiary, A., Cochrane, S. A., Mercier, P., McKay, R. T., Miskolzie, M., Sit, C. S., & Vederas, J. C. (2017) · Journal of the American Chemical Society · doi:10.1021/jacs.7b04728 · Cited by 54
Bacteriocin-mediated competition in cystic fibrosis lung infections
Ghoul, M., West, S. A., Johansen, H. K., Molin, S., Harrison, O. B., Maiden, M. C. J., Jelsbak, L., Bruce, J. B., & Griffin, A. S. (2015) · Proceedings of the Royal Society B Biological Sciences · doi:10.1098/rspb.2015.0972 · Cited by 52
Effect of Acetic Acid on Bacteriocin Production by Gram-Positive
Ge, J., Kang, J., & Ping, W. (2019) · Journal of Microbiology and Biotechnology · doi:10.4014/jmb.1905.05060 · Cited by 50
Put a Bow on It: Knotted Antibiotics Take Center Stage
Tan, S., Moore, G., & Nodwell, J. R. (2019) · Antibiotics · doi:10.3390/antibiotics8030117 · Cited by 48
Colicins and Salmocins – New Classes of Plant-Made Non-antibiotic Food Antibacterials
Hahn‐Löbmann, S., Stephan, A., Schulz, S., Schneider, T., Шаверський, А. А., Tusé, D., Giritch, A., & Gleba, Y. Y. (2019) · Frontiers in Plant Science · doi:10.3389/fpls.2019.00437 · Cited by 47
Pulsed UV as a potential surface sanitizer in food production processes to ensure consumer safety
Garvey, M., & Rowan, N. J. (2019) · Current Opinion in Food Science · doi:10.1016/j.cofs.2019.03.003 · Cited by 45
Self-citationBacteriocin Occurrence and Activity in Escherichia coli Isolated from Bovines and Wastewater
Cameron, A., Zaheer, R., Adator, E. H., Barbieri, R., Reuter, T., & McAllister, T. A. (2019) · Toxins · doi:10.3390/toxins11080475 · Cited by 43
Synthesis of Trypsin-Resistant Variants of the Listeria -Active Bacteriocin Salivaricin P
O'Shea, E. F., O’Connor, P. M., Cotter, P. D., Ross, R. P., & Hill, C. (2010) · Applied and Environmental Microbiology · doi:10.1128/aem.00523-10 · Cited by 42
Covalent Structure and Bioactivity of the Type AII Lantibiotic Salivaricin A2
Geng, M., Austin, F. W., Shin, R., & Smith, L. (2017) · Applied and Environmental Microbiology · doi:10.1128/aem.02528-17 · Cited by 36
Structure analysis of the two-peptide bacteriocin lactococcin G by introducing d-amino acid residues
Oppegård, C., Rogne, P., Kristiansen, P. E., et al. (2010) · Microbiology · doi:10.1099/mic.0.038430-0 · Cited by 35
Characteristics of Bacteriocins and Use as Food Antimicrobials in the United States
O’Bryan, C. A., Koo, O. K., Sostrin, M. L., Ricke, S. C., Crandall, P. G., & Johnson, M. G. (2017) · Elsevier eBooks · doi:10.1016/b978-0-12-811835-1.00015-4 · Cited by 33
Cited by
Bacteriocins: Properties and potential use as antimicrobials
Darbandi, A., Asadi, A., Mahdizade Ari, M., Ohadi, E., Talebi, M., Halaj Zadeh, M., Darb Emamie, A., Ghanavati, R., & Kakanj, M. (2022) · Journal of Clinical Laboratory Analysis · doi:10.1002/jcla.24093 · Cited by 500
Hernández-González, J. C., Martínez-Tapia, A., Lazcano-Hernández, G., García-Pérez, B. E., & Castrejón-Jiménez, N. S. (2021) · Animals · doi:10.3390/ani11040979 · Cited by 256
Bacteriocin diversity, function, discovery and application as antimicrobials
Sugrue, I., Ross, R. P., & Hill, C. (2024) · Nature Reviews Microbiology · doi:10.1038/s41579-024-01045-x · Cited by 254
Natural bacterial isolates as an inexhaustible source of new bacteriocins
Lozo, J., Topisirovic, L., & Kojic, M. (2021) · Applied Microbiology and Biotechnology · doi:10.1007/s00253-020-11063-3 · Cited by 63
Metadata
- Authors
- Meade, E., Slattery, M. A., & Garvey, M.
- Venue
- Antibiotics
- Publisher
- MDPI AG
- Published
- 2020-01-16
- Volume
- 9
- Issue
- 1
- Pages
- 32
- ISSN
- 2079-6382 (ISSN-L)
- OpenAlex
- W2999266361
- Cited by
- 320
- References
- 51
- FWCI
- 26.52
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.